Clinical trial No longer in our active list Phase 2 Interventional Ages 35 and up

Using platelet-rich plasma to treat knee osteoarthritis

Official title: Efectividad Del Plasma Rico en Plaquetas (PRP) Para la disminución Objetiva Del Dolor y la recuperación Funcional Del Miembro Inferior en Osteoartritis de Rodilla. Evaluación de Alternativas metodológicas

Run by Universidad Nacional de Entre Rios · NCT05825105 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing two different ways of using platelet-rich plasma to see which one helps people with knee osteoarthritis feel less pain and move better.

Quick facts

PhasePhase 2
Study typeInterventional
Ages35 Years and up
SexAll
Enrollment110 (estimated)
SponsorUniversidad Nacional de Entre Rios
Academic / other
Locations1 site (Oro Verde, Entre Ríos)
Trial IDNCT05825105 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals over 35 years old with a radiological diagnosis of knee osteoarthritis and a WOMAC score of 24 or higher.

Probably not a fit

Patients with knee prostheses, rheumatoid arthritis, or other specified blood disorders will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of platelet-rich plasma (PRP) treatment for patients suffering from knee osteoarthritis (OA). It aims to compare two different methods of PRP application to determine which is more effective in reducing pain and improving joint function. Participants will be assessed using the WOMAC scale and other measures to gauge their response to the treatment. The study seeks to optimize PRP preparation and identify patient characteristics that may influence treatment outcomes.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce pain and improve mobility for patients with knee osteoarthritis.

How similar studies have gone: Previous studies have shown promising results with platelet-rich plasma treatments for osteoarthritis, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Radiological diagnosis of knee OA
* Age over 35 years old
* WOMAC value of 24 or higher at the time of recruitment

Exclusion Criteria:

* Patients with knee prosthesis, rheumatoid arthritis, contralateral lower limb amputation, any type of blood dyscrasia, hypofibrinogenemia, depot pool syndrome, or any other form of thrombocytopathy or chronic leukocytosis will be excluded from the study.
* Patients with anticoagulant or acute coagulopathies, as well as carriers of any infectious disease or superficial infection at the puncture site, will be temporarily excluded from the study until their clinical recovery is confirmed by laboratory testing.

Where it's running

  • Institute for Research and Development in Bioengineering and Bioinformatics (IBB-CONICET-UNER)
    Oro Verde, Entre Ríos, Argentina
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.